FDA Clears T2 Biosystems’ Key Update in Sepsis Battle
T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
- Latest
- Trending
T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...
Investment firm Jefferies maintains its Buy rating on Vestis Corp, highlighting its well-executed turnaround strategy and potential for margin improvement ...
WiSA Technologies, Inc. has priced its public offering at approximately $10 million as part of its expansion plans in the ...
UBS upgrades GE HealthCare Technologies to Neutral, raises price target to $88. Positive outlook for company's margin improvement and revenue ...
UBS predicts S&P 500 will reach 5,300, exceeding 7% growth rate. Positive earnings and economic outlook contribute to optimistic market ...
Mining billionaire Robert Friedland's company, HPX, is partnering with Liberia's government and Guma Africa Group for a $5 billion infrastructure ...
Bitcoin and Ethereum remain steady, with slight declines but still above key levels. Some cryptocurrencies gained traction while others faced ...
Gilead Sciences acquires CymaBay Therapeutics for $4.3 billion to expand its liver disease portfolio, including access to potential treatment for ...
Investment firm Piper Sandler has upgraded Cass Information Systems' rating to Overweight and increased its price target. Analysts are optimistic ...
Rail Vision has unveiled its next-generation AI-based computer, aimed at enhancing railway safety and preventing accidents by detecting potential hazards. ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.